Kim IY - Search Results

1

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.

Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY. Lee DH, et al. Among authors: kim iy. Clin Cancer Res. 1998 Mar;4(3):535-8. Clin Cancer Res. 1998. PMID: 9533519

2

The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients.

Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, Lerner SP, Morton RA Jr. Lee DH, et al. Among authors: kim iy. Yonsei Med J. 1999 Apr;40(2):118-23. doi: 10.3349/ymj.1999.40.2.118. Yonsei Med J. 1999. PMID: 10333714 Free article.

3

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.

Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. Tokunaga H, et al. Among authors: kim iy. Clin Cancer Res. 1999 Sep;5(9):2520-5. Clin Cancer Res. 1999. PMID: 10499628

4

Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.

Yang SC, Lee DH, Hong SJ, Chung BH, Kim IY. Yang SC, et al. Among authors: kim iy. Yonsei Med J. 1997 Jun;38(3):155-9. doi: 10.3349/ymj.1997.38.3.155. Yonsei Med J. 1997. PMID: 9259615 Free article.

5

Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.

Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK, Morton RA. Kim IY, et al. Cancer Res. 2000 Jun 1;60(11):2840-4. Cancer Res. 2000. PMID: 10850425

6

Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.

Lee GT, Kang DI, Ha YS, Jung YS, Chung J, Min K, Kim TH, Moon KH, Chung JM, Lee DH, Kim WJ, Kim IY. Lee GT, et al. Among authors: kim iy, kim wj, kim th. Br J Cancer. 2014 Mar 18;110(6):1634-44. doi: 10.1038/bjc.2014.23. Epub 2014 Feb 11. Br J Cancer. 2014. PMID: 24518599 Free PMC article.

7

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.

Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM, Lerner SP. Kim JH, et al. Among authors: kim iy. Cancer. 2001 Sep 15;92(6):1475-83. doi: 10.1002/1097-0142(20010915)92:6<1475::aid-cncr1472>3.0.co;2-x. Cancer. 2001. PMID: 11745225

8

Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients.

Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C. Kim IY, et al. Clin Cancer Res. 1998 Jul;4(7):1625-30. Clin Cancer Res. 1998. PMID: 9676836

9

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.

Shariat SF, Kim JH, Andrews B, Kattan MW, Wheeler TM, Kim IY, Lerner SP, Slawin KM. Shariat SF, et al. Among authors: kim iy, kim jh. Cancer. 2001 Dec 15;92(12):2985-92. doi: 10.1002/1097-0142(20011215)92:12<2985::aid-cncr10175>3.0.co;2-5. Cancer. 2001. PMID: 11753975

10

Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues.

Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C. Kim IY, et al. Clin Cancer Res. 1996 Aug;2(8):1255-61. Clin Cancer Res. 1996. PMID: 9816295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,127 results

Search Page

Filters